Seelos Therapeutics Inc (SEEL)

[mean gene]

What I do not understand is that if everything hinges on the success of Fispemifene, then why all the bashing of Pascoe and his team. Fispemifene came into play under Pascoe's watch! I personally do not agree that everything is dependent on the success of Fispemifene. The revival of Rayva and the repurchase of Vitaros in the U.S. imo were very well executed under Pascoe's watch. It sounds like I am praising management, I am not, but I do want to give credit when it is due. I understand the failures the management team has had and the subsequent drop in pps, but I do not believe that Pascoe and his team are only interested in enriching themselves at the the expense of us shareholders. Sarissa and Aspire only interest imo is the same as ours and that is to make money and if they do, so will we! That may mean that someone like myself with an average price per share of $3.42 may not make a whole lot of money;however, I do like my chances a whole lot more now than when the company was under Dr. Damaj and we did not have a product approved or launched. I thought it was a good investment then and I think it is a better investment now!